TECNIS PureSee IOL, Model DEN00V TECNIS PureSee Toric II IOLs, Model DET150, DET225, DET300, DET375
Johnson & Johnson Surgical Vision, Inc. · Decision date Mar 11, 2026
What did the FDA approve?
FDA records P980040/S176 as a supplement to PMA P980040, with the supplement type “Panel Track”. The recorded decision is approval, dated Mar 11, 2026.
FDA approval order statement
Approval for the TECNIS SIMPLICITY Delivery System is used to fold and assist in inserting the TECNIS PureSee IOL, which is indicated for primary implantation for the visual correction of aphakia in adult patients with less than 1 diopter of pre-existing corneal astigmatism in whom a cataractous lens has been removed. The lens mitigates the effects of presbyopia by providing an extended depth of focus. Compared to an aspheric monofocal IOL, the TECNIS PureSee IOL provides improved intermediate visual acuity, while maintaining comparable distance visual acuity. The lens is intended for capsular bag placement only. The TECNIS SIMPLICITY Delivery System is used to fold and assist in inserting the TECNIS PureSee Toric II IOLs, which are indicated for primary implantation for the visual correction of aphakia and for reduction of refractive astigmatism in adult patients with greater than or equal to 1 diopter of preoperative corneal astigmatism in whom a cataractous lens has been removed. The lenses mitigate the effects of presbyopia by providing an extended depth of focus. Compared to an aspheric monofocal IOL, the TECNIS PureSee Toric II IOLs provide improved intermediate visual acuity, while maintaining comparable distance visual acuity. The lenses are intended for capsular bag placement only.
- Regulatory pathway
- PMA supplement
- Supplement type
- Panel Track
- Clinical specialty
- Ophthalmic
- Decision date
- Mar 11, 2026
- FDA change category
- Change Design/Components/Specifications/Material
Regulatory record facts
- Identifier
- P980040/S176
- Regulatory pathway
- PMA supplement
- Product code
- HQL
- Decision code
- APPR
- Decision date
- Mar 11, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: intraocular lens.
- Product code
- HQL
- FDA device class
- 3
For the original device and its historical approval scope, see PMA P980040. Subsequent supplements may change the device or its indications.
FDA decision timeline
P980040 · Original PMA
SENSAR SOFT ACRYLIC UV-LIGHT ABSORBING POSTERIOR CHAMBER INTRAOCULAR LENS
P980040/S175 · Related supplement
TECNIS Odyssey Toric II IOL with TECNIS SIMPLICITY Delivery System, Model DRT
P980040/S176 received
Application receipt date recorded by FDA.
P980040/S177 · Related supplement
TECNIS Toric II 1-Piece IOLs, ZCU TECNIS Symfony Toric II Extended Range of Vision IOLs, ZXU TECNIS Eyhance Toric II IO
P980040/S171 · Related supplement
SENSAR Soft Acrylic Posterior Chamber IOL, SENSAR 1-piece IOL, TECNIS 1-Piece IOL, TECNIS Multifocal 1-Piece IOL, TECNIS
P980040/S174 · Related supplement
TECNIS Odyssey IOL with TECNIS SIMPLICITY Delivery System (DRN00V); TECNIS Odyssey Toric II IOLs with TECNIS SIMPLICITY
P980040/S178 · Related supplement
TECNIS Symfony Toric II OptiBlue Extended Range of Vision IOL with TECNIS Simplicity Delivery System, Models DXW150-375;
P980040/S179 · Related supplement
TECNIS SIMPLICITY Delivery System
P980040/S181 · Related supplement
SENSAR 1-piece IOL, AAB00; SENSAR Soft Acrylic Posterior Chamber IOL, Models AR40e, AR40E, and AR40M; TECNIS 1-Piece I
P980040/S176 · FDA decision
Panel Track
P980040/S182 · Related supplement
TECNIS Eyhance Toric II IOLs with SmartLOAD Delivery Technology (GIU150-600)
P980040/S183 · Related supplement
SENSAR 3-Piece Monofocal IOL, Models, AR40e, AR40E, AR40M, AR40MN
P980040/S184 · Related supplement
SENSARTM 1-Piece IOL, AAB00; TECNISTM 1-Piece IOL with TECNIS Simplicity Delivery System, DCB00; TECNISTM 1-Piece OptiB
P980040/S186 · Related supplement
SENSAR 3-Piece Monofocal IOL, SENSAR 1-piece IOL, TECNIS Multi-focal 1-pc, TECNIS 1-PC OptiBlue IOL, TECNIS OptiBlue 1-P
Timeline entries are records held by MedtechLedger for P980040. View FDA’s full supplement list.
Related devices and submissions
Same PMA: P980040
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| Johnson & Johnson Surgical Vision, Inc. | PMA approval | Feb 3, 2000 | FDA | |
| Johnson & Johnson Surgical Vision, Inc. | PMA supplement | Jul 22, 2025 | FDA | |
| Johnson & Johnson Surgical Vision, Inc. | PMA supplement | Sep 2, 2025 | FDA | |
| Johnson & Johnson Surgical Vision, Inc. | PMA supplement | Sep 10, 2025 | FDA | |
| Johnson & Johnson Surgical Vision, Inc. | PMA supplement | Sep 11, 2025 | FDA | |
| Johnson & Johnson Surgical Vision, Inc. | PMA supplement | Oct 24, 2025 | FDA | |
TECNIS SIMPLICITY Delivery SystemP980040/S179 | Johnson & Johnson Surgical Vision, Inc. | PMA supplement | Dec 16, 2025 | FDA |
| Johnson & Johnson Surgical Vision, Inc. | PMA supplement | Jan 12, 2026 | FDA | |
| Johnson & Johnson Surgical Vision, Inc. | PMA supplement | May 19, 2026 | FDA | |
| Johnson & Johnson Surgical Vision, Inc. | PMA supplement | Jun 3, 2026 | FDA | |
| Johnson & Johnson Surgical Vision, Inc. | PMA supplement | Jul 23, 2026 | FDA | |
| Johnson & Johnson Surgical Vision, Inc. | PMA supplement | Oct 19, 2026 | FDA |
Explore the linked device profile
Other records with product code HQL
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
FINEVISION HP Trifocal IOLsP240038/S004 | Beaver-Visitec International, Inc. | PMA supplement | Oct 27, 2026 | FDA |
CT LUCIA Intraocular Lenses (IOLs)P100016/S028 | Carl Zeiss Meditec Production, LLC | PMA supplement | Oct 23, 2026 | FDA |
enVista Hydrophobic Acrylic Intraocular LensP910056/S067 | Bausch + Lomb, Inc. | PMA supplement | Oct 23, 2026 | FDA |
| Johnson & Johnson Surgical Vision, Inc. | PMA supplement | Oct 19, 2026 | FDA | |
enVista Hydrophobic Acrylic Intraocular LensP910056/S066 | Bausch + Lomb, Inc. | PMA supplement | Oct 14, 2026 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Johnson & Johnson Surgical Vision, Inc.
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- 31 Technology Dr., Suite 200, Irvine, CA, 92618
Sources and methodology
- Original FDA record: P980040/S176
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 20, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records






